Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Hemoadsorpion in Patients With Septic Shock: Efficacy and Safety Evaluation. A Pilot Multicenter Randomized Controlled Trial

NCT07661303 is registered in ClinicalTrials.gov with Moscow Multidisciplinary Clinical Center "Kommunarka" as lead sponsor.

NCT NCT07661303
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07661303 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Hemoadsorpion in Patients With Septic Shock: Efficacy and Safety Evaluation. A Pilot Multicenter Randomized Controlled Trial
Lead sponsor
Moscow Multidisciplinary Clinical Center "Kommunarka"
Phase
Not applicable
Overall status
Not yet recruiting
Start date
June 25, 2026
Completion date
December 25, 2027
Enrollment
76 (estimated)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

septic shock